Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures

BACKGROUND: Thrombotic disorders remain one of the leading causes of death in the Western world. Dabigatran appeared as an alternative to warfarin for anticoagulation in the treatment of atrial fibrillation (AF). The risk associated with bleeding due to its use has been documented in several randomi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Arq Bras Cardiol
Autori principali: Andrade, Marcus Vinicius Santos, Andrade, Luciana Azevedo Prata, Bispo, Alan Freitas, Freitas, Luana de Alencar, Andrade, Milena Quadros Sampaio, Feitosa, Gilson Soares, Feitosa-Filho, Gilson Soares
Natura: Artigo
Lingua:Inglês
Pubblicazione: Sociedade Brasileira de Cardiologia - SBC 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6173350/
https://ncbi.nlm.nih.gov/pubmed/30088558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5935/abc.20180137
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi